Clinical Trial Update: Ranger™ and Ranger™ SL (OTW) DCB) in China [NA]

View source ↗

Summary

This clinical trial update notes that the Ranger and Ranger SL paclitaxel-coated balloon catheters for femoropopliteal artery lesions in China have completed st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoropopliteal Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• Ranger (paclitaxel-coated balloon catheter)
• Ranger SL (OTW) (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Femoropopliteal Artery Lesions | NA | Status: COMPLETED | Results posted: 2022-03-10